Institution · Viewpoint Molecular Targeting (United States)

Most cited papers from Viewpoint Molecular Targeting (United States)

Viewpoint Molecular Targeting (United States)

What are the most cited papers from Viewpoint Molecular Targeting (United States)?

The most cited paper from Viewpoint Molecular Targeting (United States) is "203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer" (Mengshi Li, Edwin A. Sagastume, Dongyoul Lee et al., 2020), with 57 citations. Next come "Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma" (56) and "Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer" (50).

Published TypeFieldAccess

Showing 19 of 19 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer Mengshi Li, Edwin A. Sagastume, Dongyoul Lee et al. · Current Medicinal Chemistry Open access	26 Aug 2020	57
2	Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma Mengshi Li, Dijie Liu, Dongyoul Lee et al. · Cancers Open access	22 Jul 2021	56
3	Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer Mengshi Li, Xiuli Zhang, Thomas P. Quinn et al. · Applied Radiation and Isotopes Open access	10 May 2017	50
4	Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based Theranostics Mengshi Li, Nicholas J. Baumhover, Dijie Liu et al. · Pharmaceutics Open access	26 Jan 2023	46
5	Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma Mengshi Li, Dijie Liu, Dongyoul Lee et al. · Molecular Pharmaceutics Open access	18 Jul 2019	32
6	High-yield cyclotron production of 203Pb using a sealed 205Tl solid target Bryce J. B. Nelson, John S. Wilson, Michael K. Schultz et al. · Nuclear Medicine and Biology	2023	22
7	Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses Kelly Davis Orcutt, Kelly E. Henry, Christine Habjan et al. · Molecules Open access	8 Sep 2022	17
8	Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy Mengshi Li, Claudia Robles-Planells, Dijie Liu et al. · European Journal of Nuclear Medicine and Molecular Imaging Open access	14 Dec 2023	9
9	Synthesis and evaluation of Diaza-Crown Ether-Backboned chelator containing hydroxamate groups for Zr-89 chelation chemistry Shuyuan Zhang, Haixing Wang, Siyuan Ren et al. · Bioorganic & Medicinal Chemistry Letters Open access	11 Jun 2022	7
10	Influence of the Molar Activity of 203/212Pb-PSC-PEG2-TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake Marc Pretze, Enrico Michler, Roswitha Runge et al. · Pharmaceuticals Open access	14 Nov 2023	6
11	Preclinical evaluation of 203/212Pb-based theranostics-dosimetry and renal toxicity. Mengshi Li, Edwin A. Sagastume, Diana Zepeda‐Orozco et al. · Journal of Nuclear Medicine	May 2020	4
12	SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice Nasim Sarrami, Bryce J. B. Nelson, Samantha Leier et al. · EJNMMI Radiopharmacy and Chemistry Open access	26 Nov 2024	3
13	Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand Therapy Mengshi Li, Claudia Robles-Planells, Dijie Liu et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	29 Sep 2023	1
14	Dipicolinic acid (DPA)-based chelators for zirconium-89 PET imaging applications Siyuan Ren, Haixing Wang, Yujie Liu et al. · Bioorganic & Medicinal Chemistry Letters Open access	21 Mar 2026	0
15	Ascorbate Preferentially Stimulates Gallium-67 Uptake in Glioblastoma Cells. Michael S. Petronek, Mengfeng Li, Jann Nagina Sarkaria et al. · PubMed Open access	2022	0
16	Urinary NGAL (uNGAL) as a Biomarker to Predict Late Nephrotoxicity in Pre-Clinical Models of Peptide-Based Radioligand Therapy (PRRT) for Cancer Gabriela Vasquez-Martinez, Mengshi Li, Prerna Rastogi et al. · Journal of the American Society of Nephrology	Nov 2022	0
17	Zelluläre Bindung von Pb-203-VMT-α-NET und Ga-68-DOTATATE in vitro Kerstin Wetzig, Roswitha Runge, Marc Pretze et al. · Nuklearmedizin - NuclearMedicine	30 Mar 2023	0
18	Charakterisierung der szintigraphischen Bildgebungseigenschaften von Pb-203 an einem SPECT/CT David Kästner, Robert Freudenberg, Henrik A. Hartmann et al. · Nuklearmedizin - NuclearMedicine	30 Mar 2023	0
19	Abschätzung und Messung der Strahlenexposition durch Pb-212 Robert Freudenberg, David Kästner, Henrik A. Hartmann et al. · Nuklearmedizin - NuclearMedicine	30 Mar 2023	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.